{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:57:08Z","timestamp":1790873828350,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,3]]},"DOI":"10.7759\/cureus.20129","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T13:33:36Z","timestamp":1638538416000},"source":"Crossref","is-referenced-by-count":2,"title":["Determination of the Risk Factors Contributing to the Development of Neuropsychiatric Lupus in a Systemic Lupus Erythematosus Cohort"],"prefix":"10.7759","author":[{"given":"Adegbenga A","family":"Bankole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taskeen  R","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa  R","family":"Strazanac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-857x(05)70137-x","article-title":"Genetics of systemic lupus erythematosus. clinical implications","volume":"26","author":"Sullivan KE","year":"2000","unstructured":"Sullivan KE. Genetics of systemic lupus erythematosus. clinical implications. Rheum Dis Clin North Am. 2000, 26:1229-56. 10.1016\/s0889-857x(05)70137-x","journal-title":"Rheum Dis Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa404","article-title":"The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?","volume":"59","author":"Govoni M","year":"2020","unstructured":"Govoni M, Hanly JG. The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?. Rheumatology (Oxford). 2020, 59:v52-62. 10.1093\/rheumatology\/keaa404","journal-title":"Rheumatology (Oxford)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","unstructured":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999, 42.599-608. 10.1002\/1529-0131(199904)42:4&lt;599::AID-ANR2&gt;3.0.CO;2-F","journal-title":"Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcreue.2018.11.003","article-title":"Antibodies associated with neuropsychiatric lupus: pathophysiological role, prevalence and diagnostic usefulness","volume":"26","author":"Marin J","year":"2019","unstructured":"Marin J, Posso-Osorio I, Vargas S, Nieto-Aristiz\u00e1bal I, R\u00edos-Serna LJ, Tob\u00f3n GJ. Antibodies associated with neuropsychiatric lupus: pathophysiological role, prevalence and diagnostic usefulness. Rev Colomb Reumatol. 2019, 26:111-7. 10.1016\/j.rcreue.2018.11.003","journal-title":"Rev Colomb Reumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.39111","article-title":"Mood disorders in systemic lupus erythematosus: results from an international inception cohort study","volume":"67","author":"Hanly JG","year":"2015","unstructured":"Hanly JG, Su L, Urowitz MB, et al.. Mood disorders in systemic lupus erythematosus: results from an international inception cohort study. Arthritis Rheumatol. 2015, 67:1837-47. 10.1002\/art.39111","journal-title":"Arthritis Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri M","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, et al.. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012, 64:2677-86. 10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer M","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al.. 2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019, 71:1400-12. 10.1002\/art.40930","journal-title":"Arthritis Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew338","article-title":"Diagnosing and attributing neuropsychiatric events to systemic lupus erythematosus: time to untie the Gordian knot?","volume":"56","author":"Tay SH","year":"2017","unstructured":"Tay SH, Mak A. Diagnosing and attributing neuropsychiatric events to systemic lupus erythematosus: time to untie the Gordian knot?. Rheumatology (Oxford). 2017, 56:i14-23. 10.1093\/rheumatology\/kew338","journal-title":"Rheumatology (Oxford)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg078","article-title":"Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus","volume":"42","author":"Yee CS","year":"2003","unstructured":"Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C. Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology (Oxford). 2003, 42:276-9. 10.1093\/rheumatology\/keg078","journal-title":"Rheumatology (Oxford)"},{"key":"ref10","unstructured":"24540 Zip Code (Danville, VA) Detailed Profile. (2021). http.\/\/www.city-data.com\/zips\/24540.html."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1327352","article-title":"Epidemiology of systemic lupus erythematosus","volume":"13","author":"Pons-Estel GJ","year":"2017","unstructured":"Pons-Estel GJ, Ugarte-Gil MF, Alarc\u00f3n GS. Epidemiology of systemic lupus erythematosus. Expert Rev Clin Immunol. 2017, 13:799-814. 10.1080\/1744666X.2017.1327352","journal-title":"Expert Rev Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14077","article-title":"Epilepsy in systemic lupus erythematosus: prevalence and risk factors","volume":"27","author":"Hopia L","year":"2020","unstructured":"Hopia L, Andersson M, Svenungsson E, Khademi M, Piehl F, Tomson T. Epilepsy in systemic lupus erythematosus: prevalence and risk factors. Eur J Neurol. 2020, 27:297-307. 10.1111\/ene.14077","journal-title":"Eur J Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1359","article-title":"Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States","volume":"21","author":"Kessler RC","year":"2012","unstructured":"Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012, 21:169-84. 10.1002\/mpr.1359","journal-title":"Int J Methods Psychiatr Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291717002781","article-title":"Trends in depression prevalence in the USA from 2005 to 2015: widening disparities in vulnerable groups","volume":"48","author":"Weinberger AH","year":"2018","unstructured":"Weinberger AH, Gbedemah M, Martinez AM, Nash D, Galea S, Goodwin RD. Trends in depression prevalence in the USA from 2005 to 2015: widening disparities in vulnerable groups. Psychol Med. 2018, 48:1308-15. 10.1017\/S0033291717002781","journal-title":"Psychol Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.2462","article-title":"Association of depression with risk of incident systemic lupus erythematosus in women assessed across 2 decades","volume":"75","author":"Roberts AL","year":"2018","unstructured":"Roberts AL, Kubzansky LD, Malspeis S, Feldman CH, Costenbader KH. Association of depression with risk of incident systemic lupus erythematosus in women assessed across 2 decades. JAMA Psychiatry. 2018, 75:1225-33. 10.1001\/jamapsychiatry.2018.2462","journal-title":"JAMA Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/art.24519","article-title":"Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus","volume":"61","author":"Bachen EA","year":"2009","unstructured":"Bachen EA, Chesney MA, Criswell LA. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum. 2009, 61:822-9. 10.1002\/art.24519","journal-title":"Arthritis Rheum"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-017-1234-1","article-title":"Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"17","author":"Zhang L","year":"2017","unstructured":"Zhang L, Fu T, Yin R, Zhang Q, Shen B. Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis. BMC Psychiatry. 2017, 17:70. 10.1186\/s12888-017-1234-1","journal-title":"BMC Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0269-8","article-title":"Neuropsychiatric lupus: a mosaic of clinical presentations","volume":"13","author":"Kivity S","year":"2015","unstructured":"Kivity S, Agmon-Levin N, Zandman-Goddard G, Chapman J, Shoenfeld Y. Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med. 2015, 13:43. 10.1186\/s12916-015-0269-8","journal-title":"BMC Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7406-8","article-title":"Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review","volume":"261","author":"Sciascia S","year":"2014","unstructured":"Sciascia S, Bertolaccini ML, Roccatello D, Khamashta MA, Sanna G. Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review. J Neurol. 2014, 261:1706-14. 10.1007\/s00415-014-7406-8","journal-title":"J Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0534-3","article-title":"Management of neuropsychiatric systemic lupus erythematosus: current approaches and future perspectives","volume":"76","author":"Magro-Checa C","year":"2016","unstructured":"Magro-Checa C, Zirkzee EJ, Huizinga TW, Steup-Beekman GM. Management of neuropsychiatric systemic lupus erythematosus: current approaches and future perspectives. Drugs. 2016, 76:459-83. 10.1007\/s40265-015-0534-3","journal-title":"Drugs"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.08.001","article-title":"Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis","volume":"41","author":"Unterman A","year":"2011","unstructured":"Unterman A, Nolte JE, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum. 2011, 41:1-11. 10.1016\/j.semarthrit.2010.08.001","journal-title":"Semin Arthritis Rheum"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.42.3.681","article-title":"Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus","volume":"42","author":"Montalb\u00e1n J","year":"1992","unstructured":"Montalb\u00e1n J, Cervera R, Font J, et al.. Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus. Neurology. 1992, 42:681-2. 10.1212\/wnl.42.3.681","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2174\/1874312901711010113","article-title":"SLE and serum complement: causative, concomitant or coincidental?","volume":"11","author":"Sandhu V","year":"2017","unstructured":"Sandhu V, Quan M. SLE and serum complement: causative, concomitant or coincidental?. Open Rheumatol J. 2017, 11:113-22. 10.2174\/1874312901711010113","journal-title":"Open Rheumatol J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2017-000236","article-title":"Cell-bound complement activation products in SLE","volume":"4","author":"Ramsey-Goldman R","year":"2017","unstructured":"Ramsey-Goldman R, Li J, Dervieux T, Alexander RV. Cell-bound complement activation products in SLE. Lupus Sci Med. 2017, 4:e000236. 10.1136\/lupus-2017-000236","journal-title":"Lupus Sci Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2000.101002116.x","article-title":"Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system","volume":"101","author":"Jongen PJ","year":"2000","unstructured":"Jongen PJ, Doesburg WH, Ibrahim-Stappers JL, Lemmens WA, Hommes OR, Lamers KJ. Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system. Acta Neurol Scand. 2000, 101:116-21. 10.1034\/j.1600-0404.2000.101002116.x","journal-title":"Acta Neurol Scand"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320938453","article-title":"Low C4 as a risk factor for severe neuropsychiatric flare in patients with systemic lupus erythematosus","volume":"29","author":"Aso K","year":"2020","unstructured":"Aso K, Kono M, Kono M, et al.. Low C4 as a risk factor for severe neuropsychiatric flare in patients with systemic lupus erythematosus. Lupus. 2020, 29:1238-47. 10.1177\/0961203320938453","journal-title":"Lupus"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz N","year":"2019","unstructured":"Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol. 2019, 15:137-52. 10.1038\/s41584-018-0156-8","journal-title":"Nat Rev Rheumatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.120975","article-title":"Corticosteroid-related central nervous system side effects","volume":"4","author":"Ciriaco M","year":"2013","unstructured":"Ciriaco M, Ventrice P, Russo G, Scicchitano M, Mazzitello G, Scicchitano F, Russo E. Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacother. 2013, 4:S94-8. 10.4103\/0976-500X.120975","journal-title":"J Pharmacol Pharmacother"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/2040622310380100","article-title":"Contemporary treatment of systemic lupus erythematosus: an update for clinicians","volume":"1","author":"Amissah-Arthur MB","year":"2010","unstructured":"Amissah-Arthur MB, Gordon C. Contemporary treatment of systemic lupus erythematosus: an update for clinicians. Ther Adv Chronic Dis. 2010, 1:163-75. 10.1177\/2040622310380100","journal-title":"Ther Adv Chronic Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307079502","article-title":"High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus","volume":"16","author":"Parker BJ","year":"2007","unstructured":"Parker BJ, Bruce IN. High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus. Lupus. 2007, 16:387-93. 10.1177\/0961203307079502","journal-title":"Lupus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/76984-determination-of-the-risk-factors-contributing-to-the-development-of-neuropsychiatric-lupus-in-a-systemic-lupus-erythematosus-cohort","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:45Z","timestamp":1707507105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/76984-determination-of-the-risk-factors-contributing-to-the-development-of-neuropsychiatric-lupus-in-a-systemic-lupus-erythematosus-cohort"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,3]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.20129","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,3]]}}}